Cargando…

BIM基因多态性与复治晚期非小细胞肺癌EGFR-TKI治疗疗效的关系

BACKGROUND AND OBJECTIVE: BIM gene is a member of the BCL-2 family, is involved in cell death. The aim of this study is to explore the relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitor (EG...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000640/
https://www.ncbi.nlm.nih.gov/pubmed/24345487
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.12.03

Ejemplares similares